exenatide and Gastroparesis

exenatide has been researched along with Gastroparesis* in 3 studies

Other Studies

3 other study(ies) available for exenatide and Gastroparesis

ArticleYear
Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2019, Volume: 51, Issue:4

    The effect of the treatment with glucagon-like peptide (GLP)-1 receptor agonists on gastric emptying in patients with diabetes with and without gastroparesis is analysed. Patients with type 2 diabetes mellitus subjected to GLP-1 receptor agonist therapy with exenatide were examined before and shortly after initiation of treatment. Gastric half-emptying time was determined by

    Topics: Breath Tests; Cohort Studies; Diabetes Mellitus, Type 2; Exenatide; Female; Gastric Emptying; Gastroparesis; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Surveys and Questionnaires

2019
Exenatide and rare adverse events.
    The New England journal of medicine, 2008, May-01, Volume: 358, Issue:18

    Topics: Adult; Bezoars; Diabetes Mellitus, Type 1; Endoscopy, Gastrointestinal; Exenatide; Female; Gastroparesis; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Peptides; Venoms

2008
Diabetic gastroparesis.
    The New England journal of medicine, 2007, Jul-26, Volume: 357, Issue:4

    Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Exenatide; Gastroparesis; Humans; Hypoglycemic Agents; Nausea; Patient Dropouts; Peptides; Randomized Controlled Trials as Topic; Venoms

2007